Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Immunology|April 9, 2016
Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodiesMarco Thomann, Katharina Reckermann, Dietmar Reusch, et al.
Plos One|December 15, 2015
Multi-Angle Effector Function Analysis of Human Monoclonal IgG GlycovariantsTetyana Dashivets, Marco Thomann, Petra Rueger, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 10, 2017
Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131)Florian Cymer, Marco Thomann, Harald Wegele, et al.
Molecular Therapy. Methods & Clinical Development|December 2, 2022
Assessing production variability in empty and filled adeno-associated viruses by single molecule mass analysesEduard H T M Ebberink, Alisa Ruisinger, Markus Nuebel, et al.
Mabs|March 14, 2020
Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approachJoanna Hajduk, Cyrill Brunner, Sebastian Malik, et al.
Plos One|August 13, 2015
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activityMarco Thomann, Tilman Schlothauer, Tetyana Dashivets, et al.
Glycobiology|December 23, 2021
Implementation of in vitro glycoengineering of monoclonal antibodies into downstream processing of industrial productionSebastian Malik, Ingrid Grunert, Matthias Freiherr von Roman, et al.
Molecular Therapy. Nucleic Acids|August 8, 2025
Breaking barriers in the sensitive and accurate mass determination of large DNA plasmids by mass photometryEduard H T M Ebberink, Evolène Deslignière, Alisa Ruisinger, et al.
Mabs|December 31, 2020
Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibodyDavid Falck, Marco Thomann, Martin Lechmann, et al.
Bioanalysis|September 7, 2019
Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisectingMarco Thomann, Sebastian Malik, Felix Kuhne, et al.
Pageof 2